Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients

Nephrology Dialysis Transplantation

Volumn 26, Issue 12, 2011, Pages 3923-3929

  Ando, Minoru ^a,b   Yanagisawa, Naoki ^a,b   Ajisawa, Atsushi ^a   Tsuchiya, Ken ^b   Nitta, Kosaku ^b  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

albuminuria; diabetes; estimated glomerular filtration rate; hepatitis C viral infection; tenofovir

Indexed keywords

ALBUMIN; CREATININE; PROTEINASE INHIBITOR; TENOFOVIR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EXPOSURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; KIDNEY DISEASE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MIXED INFECTION; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; URINARY EXCRETION;

ALBUMINURIA; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK FACTORS; TIME FACTORS;

EID: 82255194351     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr129     Document Type: Article

References (36)

1. Eggers PW, Kimmel PL. Is there an epidemic of HIV infection in the US ESRD program? J Am Soc Nephrol 2004; 15: 2477-2485 (Pubitemid 39159349)
2. Yanagisawa N, Ando M, Ajisawa A et al. Clinical characteristics of kidney disease in Japanese HIV-infected patients. Nephron Clin Pract 2011; 118: c285-c291
3. Cheung CY, Wong KM, Lee MP et al. Prevalence of chronic kidney disease in Chinese HIV-infected patients. Nephrol Dial transplant 2007; 22: 3186-3190 (Pubitemid 350202545)
4. Winston J, Deray G, Hawkins T et al. Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis 2008; 47: 1449-1457
5. Post FA, Holt SG. Recent developments in HIV and the kidney. Curr Opin Infect Dis 2009; 22: 43-48
6. Taal MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. Kidney Int 2006; 70: 1694-1705 (Pubitemid 44684800)
7. Kalaitzidis RG, Bakiris GL. Prehypertension: Is it relevant for nephrologists? Kidney Int 2010; 77: 194-200
8. Jafar TH, Schmid CH, Landa M et al. Angiotensin-convertingenzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data. Ann Intern Med 2001; 135: 73-87 (Pubitemid 32661190)
9. Mogensen CE. Twelve shifting paradigms in diabetic renal disease and hypertension. Diabetes Res Clin Pract 2008; 82 (Suppl 1): S2-S9
10. Kasiske BL, Lakatuab JD, Ma JZ et al. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 1998; 31: 954-961 (Pubitemid 28265191)
11. Gansevoort RT, Bakker SJL, de Jong PE. Early detection of progressive chronic kidney disease: is it feasible? J Am Soc Nephrol 2006; 17: 1218-1220 (Pubitemid 43673400)
12. Mocroft A, Kirk O, Gatell J et al. Chronic renal failure among HIV-1-infected patients. AIDS 2007; 21: 1119-1127 (Pubitemid 46763282)
13. Daugas E, Rougier JP, Hill G. HAART-related nephropathies in HIVinfected patients. Kidney Int 2005; 67: 393-403
14. Izzedine H, Harris M, Perazella M. The nephrotoxic effect of HAART. Nat Rev Nephrol 2009; 5: 563-573
15. Côté HCF, Magil AB, Harris M et al. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy. Antivir Ther 2006; 11: 79-86
16. Matsuo S, Imai E, Horio M et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2008; 51: 914-924
17. Ando M, Iwamoto Y, Suda A et al. New insights into the thrombopoietic status of patients on dialysis through the evaluation of megakaryocytopoiesis in bone marrow and of endogenous thrombopoietin levels. Blood 2001; 97: 915-921 (Pubitemid 32154274)
18. Imai E, Horio M, Watanabe T et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009; 13: 621-630
19. Sack DB, Bruns DE, Golstein DE et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002; 48: 436-472 (Pubitemid 34174577)
20. Retnakaran R, Cull CA, Thorne KI et al. Risk factors for renal dysfunction in type 2 diabetes: UK Prospective Diabetes Study 74. Diabetes 2006; 55: 1832-1839 (Pubitemid 44324140)
21. Heo NJ, Ahn HM, Lee TW et al. Very low-grade albuminuria reflects susceptibility to chronic kidney disease in combination with cardiovascular risk factors. Hypertens Res 2010; 33: 573-578
22. Szczech LA, Grunfeld C, Scherzer R et al. Microalbuminuria in HIV infection. AIDS 2007; 21: 1003-1019
23. Szczech LA, Golub ET, Springer G et al. Highly active antiretroviral therapy reduces urinary albuminuria excretion women with HIV infection. J Aquir Immune Defic Syndr 2008; 48: 360-361
24. Vita JA. Endothelial function and clinical outcome. Heart 2005; 91: 1278-1279 (Pubitemid 41360940)
25. Meigs JB, Hu FB, Rifai N et al. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004; 291: 1978-1986 (Pubitemid 38544279)
26. Choi AI, Li W, Deeks SG et al. Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation 2010; 121: 651-658
27. Choi A, Scherzer R, Bacchetti P et al. Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. Am J Kidney Dis 2010; 56: 872-882
28. Liangpunsakul S, Chalasani N. Relationship between hepatitis C and microalbuminuria: Results from the NHANES III. Kidney Int 2005; 67: 285-290 (Pubitemid 40019251)
29. Tsui JI, Vittinghoff E, Shlipak MG et al. Relationship between hepatitis C and chronic kidney disease: Results from the third national health and nutrition examination survey. J Am Soc Nephrol 2006; 17: 1168-1174
30. Sabry AA, Sobh MA, Irving WL et al. A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant 2002; 17: 239-245 (Pubitemid 34157137)
31. Hostetter TH, Olson JL, Rennke HG et al. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241: F85-F93 (Pubitemid 11033923)
32. Fox CS, Larson MG, Leip EP et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844-850 (Pubitemid 38543772)
33. Goicoechea M, Liu S, Best B et al. Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy. J Infect Dis 2008; 197: 102-108 (Pubitemid 351263473)
34. Kshirsagar AV, Bang H, Bomback A et al. A simple algorithm to predict incident kidney disease. Arch Intern Med 2008; 168: 2466-2473
35. Bang H, Vupputuri S, Shoham DA et al. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med 2007; 167: 374-381 (Pubitemid 46333938)
36. Barraclough K, Er L, Ng F et al. A comparison of the predictive performance of different methods of kidney function estimation in a well-characterized HIV-infected population. Nephron Clin Pract 2009; 111: c39-c48